The potential benefits of low-molecular-weight heparins in cancer patients

od Robert, Francisco
Wydane 2010

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma

od Jamil, Muhammad Omer, Jerome, Mary S, Miley, Deborah, Selander, Katri S, Robert, Francisco
Wydane w Lung Cancer (Auckl) (2017)

Vorinostat in solid and hematologic malignancies

od Siegel, David, Hussein, Mohamad, Belani, Chandra, Robert, Francisco, Galanis, Evanthia, Richon, Victoria M, Garcia-Vargas, José, Sanz-Rodriguez, Cesar, Rizvi, Syed
Wydane 2009

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

od Robert, Francisco, Sandler, Alan, Schiller, Joan H., Liu, Glenn, Harper, Karen, Verkh, Lev, Huang, Xin, Ilagan, Jennifer, Tye, Lesley, Chao, Richard, Traynor, Anne M.
Wydane 2009

Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324

od Blumenschein, George R., Paulus, Rebecca, Curran, Walter J., Robert, Francisco, Fossella, Frank, Werner-Wasik, Maria, Herbst, Roy S., Doescher, Philip O., Choy, Hak, Komaki, Ritsuko
Wydane 2011

EGFR Expression and Survival in Patients Given Cetuximab and Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0324

od Komaki, Ritsuko, Paulus, Rebecca, Blumenschein, George R, Curran, Walter J., Robert, Francisco, Thariat, Juliette, Werner-Wasik, Maria, Choy, Hak, Hirsch, Fred R., Ang, K. Kian
Wydane 2014

Pilot Phase II Study of Metronomic Chemotherapy in Combination with Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

od Jones, Benjamin S., Jerome, Mary S., Miley, Deborah, Jackson, Bradford E., DeShazo, Mollie R., Reddy, Vishnu V.B., Singh, Karan P., Brown, Olivia C., Robert, Francisco
Wydane w Lung Cancer (2017)

Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer

od Ou, Sai-Hong Ignatius, Govindan, Ramaswamy, Eaton, Keith D., Otterson, Gregory A., Gutierrez, Martin E., Mita, Alain C., Argiris, Athanassios, Brega, Nicoletta M., Usari, Tiziana, Tan, Weiwei, Ho, Steffan N., Robert, Francisco
Wydane w J Thorac Oncol (2016)

An Open Label Phase 1b Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer

od Gordon, Michael S., Robert, Francisco, Matei, Daniela, Mendelson, David S., Goldman, Jonathan W., Chiorean, E. Gabriela, Strother, Robert M., Seon, Ben K., Figg, William D., Peer, Cody J., Alvarez, Delia, Adams, Bonne J., Theuer, Charles P., Rosen, Lee S.
Wydane w Clin Cancer Res (2014)

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

od Rudin, Charles M, Pietanza, M Catherine, Bauer, Todd M, Ready, Neal, Morgensztern, Daniel, Glisson, Bonnie S, Byers, Lauren A, Johnson, Melissa L, Burris, Howard A, Robert, Francisco, Han, Tae H, Bheddah, Sheila, Theiss, Noah, Watson, Sky, Mathur, Deepan, Vennapusa, Bharathi, Zayed, Hany, Lally, Satwant, Strickland, Donald K, Govindan, Ramaswamy, Dylla, Scott J, Peng, Stanford L, Spigel, David R
Wydane w Lancet Oncol (2016)